VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 study

Autor: Yuen, Man-Fung *, Lim, Young-Suk, Yoon, Ki Tae, Lim, Tien-Huey, Heo, Jeong, Tangkijvanich, Pisit, Tak, Won Young, Thanawala, Vaidehi, Cloutier, Daniel, Mao, Shenghua, Arizpe, Andre, Cathcart, Andrea L, Gupta, Sneha V, Hwang, Carey, Gane, Edward
Zdroj: In The Lancet Gastroenterology & Hepatology December 2024 9(12):1121-1132
Databáze: ScienceDirect